Loading clinical trials...
Loading clinical trials...
The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value \< 0.8 mmol/l) in international critical care settings
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire Vaudois
Collaborators
NCT07093203 · Intra-Abdominal Infection, Candida, and more
NCT07262320 · Dialysis, Critically Ill Acute Kidney Injury, and more
NCT06840756 · Red Blood Cell Transfusions, Sex Differences, and more
NCT07448805 · Diabetes Mellitus, Blood Sugar, and more
NCT07222007 · Critically Ill, Intubation Complication, and more
Tartu University Hospital
Tartu
Hôpital Pasteur 2
Nice
Lausanne University Hospital
Lausanne, Canton of Vaud
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions